Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Pernix Therapeutics Holdings Inc (PTX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7104
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR) opioid agonist that is indicated for pain severe management, and long-term opioid treatment; a non-narcotic, non-addictive, and non-scheduled prescription sleep aid to treat insomnia; an antibiotic for infections of middle ear; and indications for depressive disorder in adults. Its branded and generic pharmaceuticals products span the therapeutic areas of neurology, psychiatry, and pain management. The company serves drug wholesalers, retail drug stores, and mass merchandisers. It has subsidiaries in the US and Ireland. Pernix Therapeutics is headquartered in Morristown, New Jersey, the US.

Pernix Therapeutics Holdings Inc (PTX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pernix Therapeutics Holdings Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Pernix Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Debt Offering 12
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Pernix Therapeutics Holdings Raises USD65 Million in Private Palcement of 8% Notes Due 2019 14
Pernix Therapeutics Holdings Raises USD220 Million in Private Placement of Notes 15
Acquisition 16
Pernix Therapeutics May Sell Itself 16
Pernix Therapeutics Holdings Inc – Key Competitors 17
Pernix Therapeutics Holdings Inc – Key Employees 18
Pernix Therapeutics Holdings Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 09, 2018: Pernix Therapeutics reports second quarter 2018 financial results 20
May 10, 2018: Pernix Therapeutics Reports First Quarter 2018 Financial Results 23
Mar 08, 2018: Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 24
Nov 07, 2017: Pernix Therapeutics Reports Third Quarter 2017 Financial Results 27
Jul 27, 2017: Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update 30
Jul 20, 2017: Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results 33
May 15, 2017: Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update 35
Mar 28, 2017: Pernix Therapeutics Announces Fourth Quarter And Full Year 2016 Financial Results 37
Corporate Communications 41
Feb 06, 2018: Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion 41
Nov 16, 2017: Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors 42
Oct 17, 2017: Pernix Therapeutics Announces Planned Departure of Chief Financial Officer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Pernix Therapeutics Holdings Inc, Medical Equipment, Key Facts, 2017 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pernix Therapeutics Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Deals By Market, 2012 to YTD 2018 8
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Pernix Therapeutics Plans to Raise up to USD50 Million in Public Offering of Shares 10
Pernix Therapeutics to Raise up to USD16 Million in Public Offering of Shares 11
Pernix Therapeutics Raises USD130 Million in Private Placement of 4.25% Notes Due 2021 12
Pernix Therapeutics Holdings Raises USD65 Million in Private Palcement of 8% Notes Due 2019 14
Pernix Therapeutics Holdings Raises USD220 Million in Private Placement of Notes 15
Pernix Therapeutics May Sell Itself 16
Pernix Therapeutics Holdings Inc, Key Competitors 17
Pernix Therapeutics Holdings Inc, Key Employees 18
Pernix Therapeutics Holdings Inc, Subsidiaries 19

List of Figures
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Pernix Therapeutics Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fukuoka Financial Group Inc:企業の戦略・SWOT・財務情報
    Fukuoka Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Fukuoka Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Otsuka Pharmaceutical Co Ltd-医療機器分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • ACell Inc:企業の製品パイプライン分析
    Summary ACell Inc (ACell) is a medical device company that offers products for wounds and various surgical procedures. The company develops and manufactures products to facilitate the body’s ability to repair and remodel tissue. Its products portfolio includes burn matrix products, multilayer wound …
  • PT Tiphone Mobile Indonesia Tbk (TELE):企業の財務・戦略的SWOT分析
    PT Tiphone Mobile Indonesia Tbk (TELE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SmarTone Mobile Communications Ltd:企業の戦略的SWOT分析
    SmarTone Mobile Communications Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Diamond Offshore Drilling Inc (DOFSQ):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DOFSQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Urban Outfitters Inc:戦略・SWOT・企業財務分析
    Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ROSEN Swiss AG:企業の戦略的SWOT分析
    ROSEN Swiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Mehler Vario System GmbH:企業の戦略・SWOT・財務情報
    Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report Summary Mehler Vario System GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cherry Rocher Neyret Chavin SA:企業の戦略・SWOT・財務情報
    Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report Summary Cherry Rocher Neyret Chavin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …
  • SeaWorld Entertainment, Inc.:企業の戦略・SWOT・財務情報
    SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report Summary SeaWorld Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Al Rajhi Banking & Investment Corporation (1120):企業の財務・戦略的SWOT分析
    Al Rajhi Banking & Investment Corporation (1120) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Buckeye Partners LP (BPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Buckeye Partners LP (Buckeye) is a provider of midstream logistic solutions. It owns and operates a diversified network of integrated assets for the transportation, storage, processing and marketing of liquid petroleum products. The company transports liquid petroleum products, including gas …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Abu Dhabi Investment Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Investment Authority (ADIA) is a sovereign wealth fund owned and managed by Emirate of Abu Dhabi. It invests directly in global financial markets along with trusted partner’s selected external managers. The company’s investment portfolio includes developed equities, small cap equit …
  • Immunicum AB (IMMU):企業の財務・戦略的SWOT分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …
  • Sumitomo Forestry Co Ltd:企業の戦略・SWOT・財務分析
    Sumitomo Forestry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Forestry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Genesis Energy Ltd (GNE):企業の財務・戦略的SWOT分析
    Genesis Energy Ltd (GNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆